CHRISTOPHER LAMBERT: Open Payments
NPI 1063801983 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,973 in 36 payments from 14 companies in 2025. Trend: 2023 $9,450 · 2024 $3,807 · 2025 $2,973
Food & beverage: $1,222Consulting: $1,100Travel & lodging: $651
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $2,186 |
| AstraZeneca Pharmaceuticals LP | 12 | $536 |
| Verona Pharma, Inc. | 2 | $39 |
| Novo Nordisk Inc | 2 | $28 |
| Kerecis Limited | 1 | $23 |
| Exact Sciences Corporation | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Abbott Laboratories | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Averitas Pharma Inc. | 1 | $19 |
Products named: VRAYLAR, FARXIGA, AIRSUPRA, BREZTRI, UBRELVY, Ohtuvayre, QULIPTA, Kerecis SurgiClose.
Industry payments across IN — which companies pay providers there.
